1. Home
  2. BWXT vs ICLR Comparison

BWXT vs ICLR Comparison

Compare BWXT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

N/A

Current Price

$195.79

Market Cap

17.9B

Sector

N/A

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$105.01

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWXT
ICLR
Founded
1867
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9B
7.1B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
BWXT
ICLR
Price
$195.79
$105.01
Analyst Decision
Buy
Buy
Analyst Count
9
13
Target Price
$204.60
$188.23
AVG Volume (30 Days)
740.8K
3.4M
Earning Date
05-26-2026
01-01-0001
Dividend Yield
0.55%
N/A
EPS Growth
16.61
N/A
EPS
3.58
N/A
Revenue
$1,687,738,000.00
N/A
Revenue This Year
$18.90
N/A
Revenue Next Year
$10.10
N/A
P/E Ratio
$54.83
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$84.21
$66.57
52 Week High
$220.57
$211.00

Technical Indicators

Market Signals
Indicator
BWXT
ICLR
Relative Strength Index (RSI) 44.92 36.15
Support Level $187.01 $66.57
Resistance Level $218.46 $155.58
Average True Range (ATR) 9.08 4.56
MACD -1.44 3.00
Stochastic Oscillator 20.98 48.33

Price Performance

Historical Comparison
BWXT
ICLR

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: